Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Tieleman

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2003
[Ximelagatran, an oral thrombin inhibitor without the need for regular monitoring of the anticoagulant status]R G Tieleman
Pacing and Clinical Electrophysiology : PACE|August 14, 2003
The pathophysiology of maintenance of atrial fibrillationR G Tieleman
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 10, 2018
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!M S Jacobs, R G Tieleman
Cardiovascular Research|July 27, 2000
The 'second factor' of tachycardia-induced atrial remodelingR G Tieleman, H J Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 6, 2014
An unexpected response to adenosineJ M Ter Maaten, R G Tieleman
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 4, 2018
Mobile health: solution or a threat?R G Tieleman, M E W Hemels
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 20, 2014
An unexpected response to adenosineJ M Ter Maaten, R G Tieleman
European Heart Journal|June 3, 2004
Cardioversion threshold, IRAF and beyondK L Merckx, R G Tieleman, H J G M Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 6, 2019
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductionsM S Jacobs, M van Hulst, Z Campmans, et al.
Circulation|September 15, 2004
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goatY Blaauw, H Gögelein, R G Tieleman, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2003
[Ximelagatran, an oral thrombin inhibitor without the need for regular monitoring of the anticoagulant status]R G Tieleman
Pacing and Clinical Electrophysiology : PACE|August 14, 2003
The pathophysiology of maintenance of atrial fibrillationR G Tieleman
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 10, 2018
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!M S Jacobs, R G Tieleman
Cardiovascular Research|July 27, 2000
The 'second factor' of tachycardia-induced atrial remodelingR G Tieleman, H J Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 6, 2014
An unexpected response to adenosineJ M Ter Maaten, R G Tieleman
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 4, 2018
Mobile health: solution or a threat?R G Tieleman, M E W Hemels
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 20, 2014
An unexpected response to adenosineJ M Ter Maaten, R G Tieleman
European Heart Journal|June 3, 2004
Cardioversion threshold, IRAF and beyondK L Merckx, R G Tieleman, H J G M Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 6, 2019
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductionsM S Jacobs, M van Hulst, Z Campmans, et al.
Circulation|September 15, 2004
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goatY Blaauw, H Gögelein, R G Tieleman, et al.
Pageof 5